Anti-IL-6/IFNb2 Antibody (Siltuximab)
Catalog No.
F1243
Anti-IL-6/IFNb2 Antibody (Siltuximab)
Featured Products
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody with anti-tumor activity. Siltuximab can be used in the study of multicentric massive lymphadenopathy (MCD) and COVID-19.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.98 kDa
Dry ice
541502-14-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Sylvant, CNTO-328, cCLB8
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05231
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL-6 His at 2 ug/mL can bind Anti-IL-6/IFNb2 Antibody (Siltuximab)
IL-6 / IFNb2
Please avoid freeze-thaw cycles.